
Gilead Sciences
OrganizationHeard in 49 episodes across 19 shows since Jan 2026
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California. It researches and develops antiviral medicines for HIV/AIDS, hepatitis B and C, influenza, and COVID-19, along with therapies in oncology, inflammation, and cell therapy. The podcast references primarily concern Gilead as a major pharmaceutical company, including debate over the pricing and commercial impact of its highly effective hepatitis C treatments.
Episodes
This week
Expert statements
Share of the conversation
Mentions of Gilead Sciences per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.
Show the data
| Day | Share (7-day) | Mentions |
|---|---|---|
| Sep 13 | 0.03‰ | 3 |
| Sep 28 | 0.01‰ | 1 |
| Oct 8 | 0.02‰ | 2 |
| Oct 10 | 0.03‰ | 1 |
| Oct 12 | 0.03‰ | 1 |
| Oct 14 | 0.05‰ | 2 |
| Oct 19 | 0.03‰ | 1 |
| Oct 20 | 0.03‰ | 1 |
| Oct 22 | 0.02‰ | 1 |
| Oct 23 | 0.05‰ | 3 |
| Oct 26 | 0.06‰ | 2 |
| Oct 27 | 0.07‰ | 3 |
| Oct 29 | 0.08‰ | 1 |
| Oct 30 | 0.06‰ | 1 |
| Nov 4 | 0.03‰ | 2 |
| Nov 6 | 0.03‰ | 2 |
| Nov 7 | 0.04‰ | 1 |
| Nov 15 | 0.02‰ | 3 |
| Nov 20 | 0.03‰ | 1 |
Email alert
Email me when Gilead Sciences comes up on a podcast
One email a week at most, with the new episodes that mention Gilead Sciences. Free, no account needed, unsubscribe in one click.
What experts have said about Gilead Sciences
8 statements · 7 positive · 1 mixed
Gilead’s hepatitis C cure will save Medicare hundreds of billions of dollars.
“They are going to save Medicare hundreds of billions of dollars.”
Open the episode · You Ain’t Seen Nothing Yet with Daniel CliftonListen at 7:10
Gilead’s anito-cel is expected to be less effective but safer than Legend’s product.
“I think it's expected that the Gilead product won't be quite as effective, but a lot safer.”
Open the episode · Episode 202 - November 6, 2026Listen at 58:46
Gilead Sciences could perform well in the third quarter.
“that, I think, could do quite well for 3Q.”
Open the episode · Closing Bell Overtime: Markets Face a Big Week as AI Takes Center Stage 10/26/26Listen at 35:53
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
49 episodes featuring Gilead Sciences, newest first
- Nov 20, 2026
Nvidia sell-off exposes wider cracks in the AI tradeCNBC's "Fast Money"Nov 20, 2026 - Nov 19, 2026
Sonja’s financial strain deepens tensions among The Golden Life castTwo Ts In A Pod with Teddi Mellencamp and Tamra JudgeNov 19, 2026 - Nov 19, 2026
RHOSLC tensions expose fractures in marriage and friendshipTwo Ts In A Pod with Teddi Mellencamp and Tamra JudgeNov 19, 2026 - Nov 18, 2026
RHONY drama turns newsletters, privilege and marriage into storylinesTwo Ts In A Pod with Teddi Mellencamp and Tamra JudgeNov 18, 2026 - Nov 17, 2026
Potomac recap questions drinking, publicity and a six-million-dollar homeTwo Ts In A Pod with Teddi Mellencamp and Tamra JudgeNov 17, 2026 - Nov 15, 2026
Ross Haber blends O’Neil discipline with Weinstein timingThe TraderLion PodcastNov 15, 2026